Navigation Links
Cellumen Establishes Collaboration in Breast Cancer Patient Stratification
Date:10/1/2007

PITTSBURGH, Oct. 1 /PRNewswire/ -- Cellumen, Inc. and Mayo Foundation for Medical Education and Research announced today the formation of a collaboration to apply cellular systems biology (CSB(TM)) profiling to breast cancer patient stratification. The goal is to create a breast cancer patient profile test to improve diagnosis and treatment for individualized medicine.

"We are very pleased to initiate an exciting research and development program with Mayo, a leader in individualized medicine," stated D. Lansing Taylor, Ph.D., CEO of Cellumen. "We are treating breast tumors as a 'system' within the breast cancer patient. A combination of breast cancer biomarkers and migratory immune cell biomarkers are being multiplexed in tissue micro-array (TMA) samples.

"We are enthusiastic about the synergy between Cellumen and Mayo in approaching this challenging opportunity," stated Taylor, "Mayo has great expertise and experience that will be applied to this collaboration. Cellumen continues to develop collaborations with the best in class partners to bring CSB solutions to the market."

About Cellumen

Cellumen, Inc. is the Cellular Systems Biology Company. Cellumen focuses on the cell as an integrated and interacting network of genes, proteins and metabolites responsible for normal and abnormal (disease) function. To promote efficient drug discovery and development, the company offers solutions to the dual challenges of efficacy and toxicity. The company's products and services have application in each of the major segments of the pharmaceutical pipeline: drug discovery ("cellular models of disease"), drug development ("cytotoxicity profiling") and clinical trials ("patient sample profiling"). The Cellumen team leverages its experience and expertise in High Content Screening, cell- based assays, advanced reagents and bioinformatics to create high value solutions. http://www.cellumen.com.


'/>"/>
SOURCE Cellumen, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Strandware Founder Establishes Consulting Firm
2. RedPrairie Establishes Asia-Pacific Headquarters in Shanghai
3. West Coast VC Establishes Midwest Presence in Madison
4. Regional collaboration is key to states future
5. Cieslewicz, Barrett talk economic collaboration
6. Congress passes bill to ease researchers collaboration worries
7. Economic collaboration in Denver sets tall goal for Wisconsin
8. Better collaboration urged to further Wisconsin biotech
9. Southeastern Wisconsin Technology Collaboration
10. Big collaboration links learners to science on a tiny scale
11. UW-Madison releases open 3D collaboration environment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... Two new educational webinars hosted by ... ALS research and how the pharmaceutical industry can make life ... Challenge: Where Does the ALS Money Go? , Featuring guest ... Time: 1:30pm ET, Register to attend , This ... Cudkowicz, Julianne Dorn Professor of Neurology at Massachusetts General Hospital ...
(Date:11/22/2014)... November 21, 2014 On November 17th ... the 2014 Emerging Medical Technologies Summit in San Francisco ... Widely regarded among Silicon Valley investors and technology ... innovation, the win also positions Briteseed to move ... competition in 2015 and compete with other elite innovation ...
(Date:11/21/2014)... Quebec , November 21, 2014 ... como responsable comercial   Mariano Rodríguez es ...   KLOX está en marcha para comenzar ... de cura de heridas de reciente aprobación en Europa   ... "la compañía") se complace al anunciar los siguientes nombramientos: ...
(Date:11/21/2014)... 20, 2014 The California ... research organization representing leading California academic institutions, biotechnology, ... PwC US today released a report revealing ... industry growth. The trend shows a 4 percent ... California Biomedical Industry Report indicates that, while ...
Breaking Biology Technology:DrugDev Webinars in December to Explore What Comes Next for ALS Research and How We Can Make Life Easier for Clinical Sites 2Insight Product Development Accelerator Member Wins MedTech Innovator Award Competition 2Insight Product Development Accelerator Member Wins MedTech Innovator Award Competition 3KLOX Technologies anuncia sus nombramientos ejecutivos 2KLOX Technologies anuncia sus nombramientos ejecutivos 3KLOX Technologies anuncia sus nombramientos ejecutivos 4KLOX Technologies anuncia sus nombramientos ejecutivos 5California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 2California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 3California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 4
... Madison, Wis. -- Implementation of RFID must be done ... technology offers are to be truly realized, attendees at Friday's ... from Patrick Sweeney, CEO of Virginia-based ODIN Technologies ... address at the lab's open house - an event that ...
... pulling all-nighters, but it happens every year twice, in fact, ... night was no exception. , ,After four months of interviewing ... morning to turn the raw ingredients of the selected companies into ... investors and business development execs who come to the event each ...
... BioSurfaces, Inc., of Madison has been licensed to ... and labeling agents, GenTel announced on Tuesday. , ,GenTel ... reagents of Kreatech Biotechnology BV of Amsterdam, ... The kits are validated for use on GenTel's PATH ...
Cached Biology Technology:RFID expert says piecemeal approach won't work 2RFID expert says piecemeal approach won't work 3RFID expert says piecemeal approach won't work 4DEMOfall - A return to simplicity 2DEMOfall - A return to simplicity 3
(Date:11/4/2014)... examining only marketing directed at children on the ... found that the majority of black, middle-income and ... tactics. , Authored by Arizona State University researcher ... the first to examine the use of child-directed ... food restaurants and its relationship to demographics. It ...
(Date:11/3/2014)... 2014 Research and Markets has announced ... Technologies, Markets and Companies" to their offering. ... methods, which have already started to play an important role ... replacing the old fashioned bone marrow transplants. Role of cells ... to become a part of medical practice. Stem ...
(Date:11/2/2014)... In this month,s issue of Physics World , ... bridging the "valley of death" to take their innovations ... argues that the gruelling challenge facing all start-up companies ... harder for physicists because of two main factors: physics-based ... and they often turn out to be a lot ...
Breaking Biology News(10 mins):Fast food marketing for children disproportionately affects certain communities 2Fast food marketing for children disproportionately affects certain communities 3Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 2Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 3The 'valley of death' facing physics start-ups 2
... has to be the niche. As air and water preceded ... stem cells in many tissues and provides factors necessary to ... stem cell dependents. A team of scientists at ... Ph.D., assistant professor in the Laboratory of Genetics, now suggests ...
... experts from across the U.S. and other countries including ... will discuss the latest findings in basic and clinical ... X Conference, to be held July 23-27 in St. ... Fragile X also will be attending the conference., Fragile ...
... in stem cell research help both scientists and regulators ... research funded by the Economic and Social Research Council. ... a balancing act where the autonomy of scientists and ... the need for comparable data. The ambition ...
Cached Biology News:Stem cell chicken and egg debate moves to unlikely arena: the testes 2Stem cell chicken and egg debate moves to unlikely arena: the testes 3Researcher helping to pioneer medical therapy for Fragile X Syndrome presents latest findings 2Standards in stem cell research 2Standards in stem cell research 3
Non-Receptor Tyrosine Kinase Sampler Kit 10 mu g each...
Mouse monoclonal [3A7.A11] to Thymidylate Synthase ( Abpromise for all tested applications). entrezGeneID: 7298 SwissProtID: P04818...
Hybridization chamblers suitable for use with all ChIP-GLAS microarrays....
PKA Sampler Kit 10 mu g each...
Biology Products: